乳腺癌护理是一个代价高昂的全球健康问题，有效的管理取决于早期发现和治疗。乳腺癌诊断可能会导致经济灾难，尤其是在低收入和中等收入国家 (LMIC)。乳腺癌护理中存在巨大的不平等，这对护理人员和患者来说是一个全球性的挑战。改善早期诊断的策略包括中低收入国家的认识和临床乳房检查以及高收入国家（HIC）的筛查。需要使用乳腺癌治疗的临床指南。 HIC 的改编指南可以解决资源有限的人群中的差异。当地制定的策略仍然为改善生存提供有效指导。需要具备及时的多学科乳腺护理会议和患者导航的综合实践单位 (IPU)，才能在高收入国家和中低收入国家实现高价值、个性化的乳腺癌管理。乳腺癌患者护理应包括使用理想患者报告结果 (PROM) 和经验测量 (PREM) 进行生活质量评估。乳腺癌结果的评估必须包括提供护理的财务成本。由此产生的价值视角应指导资源分配和计划优先事项。必须通过将社会和经济研究的结果转化为实践并解决临床乳腺癌研究中的系统性不平等来提高护理的价值。癌症生存计划必须在各地实施。未来，转移性乳腺癌患者的治疗必须得到更多关注，尤其是中低收入国家。© 作者 2024。由牛津大学出版社出版。

Breast cancer care is a costly global health issue where effective management depends on early detection and treatment. A breast cancer diagnosis can result in financial catastrophe especially in low- and middle-income countries (LMIC). Large inequities in breast cancer care are observed and represent a global challenge to caregivers and patients. Strategies to improve early diagnosis include awareness and clinical breast examination in LMIC, and screening in high-income countries (HIC). The use of clinical guidelines for the management of breast cancer is needed. Adapted guidelines from HIC can address disparities in populations with limited resources. Locally developed strategies still provide effective guidance in improving survival. Integrated practice units (IPU) with timely multidisciplinary breast care conferences and patient navigators are required to achieve high-value, personalized breast cancer management in HIC as well as LMIC. Breast cancer patient care should include a quality of life evaluation using ideally patient-reported outcomes (PROM) and experience measurements (PREM). Evaluation of breast cancer outcomes must include the financial cost of delivered care. The resulting value perspective should guide resource allocation and program priorities. The value of care must be improved by translating the findings of social and economic research into practice and resolving systemic inequity in clinical breast cancer research. Cancer survivorship programs must be put in place everywhere. The treatment of patients with metastatic breast cancer must require more attention in the future, especially in LMIC.© The Author(s) 2024. Published by Oxford University Press.